Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-20-135891

Chief Operating Officer bought 207,000 shares at $0.69 ($143,824)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bertrand William C JR Chief Operating Officer 2020-12-14 Purchase +207,000 $0.69 $143,824 284,808 D
Open-market purchases · 207,000 sh · avg $0.69 · $143,824
Loading xslF345X03/tm2038497-1_4.xml…